A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency

Regarding “A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency”

10.1016/j.jvs.2010.03.030 ◽

2010 ◽

Vol 52 (2) ◽

pp. 533 ◽

Cited By ~ 2

Author(s):

Byung-Boong Lee

Keyword(s):

Endovascular Treatment ◽

Venous Insufficiency ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Regarding “A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency”

10.1016/j.jvs.2010.05.136 ◽

2010 ◽

Vol 52 (6) ◽

pp. 1748 ◽

Cited By ~ 1

Author(s):

Jay Requarth

Keyword(s):

Endovascular Treatment ◽

Venous Insufficiency ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency

10.1016/j.jvs.2009.07.096 ◽

2009 ◽

Vol 50 (6) ◽

pp. 1348-1358.e3 ◽

Cited By ~ 246

Author(s):

Paolo Zamboni ◽

Roberto Galeotti ◽

Erica Menegatti ◽

Anna Maria Malagoni ◽

Sergio Gianesini ◽

...

Keyword(s):

Endovascular Treatment ◽

Venous Insufficiency ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Regarding “A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency”

10.1016/j.jvs.2010.08.025 ◽

2010 ◽

Vol 52 (6) ◽

pp. 1749

Author(s):

Joan Skurnick

Keyword(s):

Endovascular Treatment ◽

Venous Insufficiency ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Azathloprise in refractory sprue. Results from a prospective open-label study

Gastroenterology ◽

10.1016/s0016-5085(01)81948-x ◽

2001 ◽

Vol 120 (5) ◽

pp. A392-A392 ◽

Cited By ~ 1

Author(s):

S NIVELONI ◽

A CHERNAVSKY ◽

S PEDREIRA ◽

R MAZURE ◽

H VAZQUEZ ◽

...

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Refractory Sprue

Normalization of urinary cortisol with the potent 11[beta]-hydroxylase inhibitor LCI699 in patients with Cushing's disease: 22-week, multicentre, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.35.oc8.4 ◽

2014 ◽

Author(s):

Beverly Biller ◽

Jacques Young ◽

Amir Hamrahian ◽

Maria Fleseriu ◽

Mark Molitch ◽

...

Keyword(s):

Cushing’S Disease ◽

Cushing's Disease ◽

Urinary Cortisol ◽

Open Label ◽

Open Label Study ◽

Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.63.gp57 ◽

2019 ◽

Author(s):

Monica Gadelha ◽

Annamaria Colao ◽

Marie Bex ◽

Rishav Mukherjee ◽

Catherine Bourad ◽

...

Keyword(s):

First Generation ◽

Somatostatin Analogues ◽

Biochemical Control ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Long Acting

Weighing the Evidence: Can We Believe an Open-Label Study?

AAP Grand Rounds ◽

10.1542/gr.16-4-39 ◽

2006 ◽

Vol 16 (4) ◽

pp. 39-39

Author(s):

B. L. Wiedermann

Keyword(s):

Open Label ◽

Open Label Study ◽

Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.94 ◽

2017 ◽

Vol 1 ◽

pp. s95 ◽

Cited By ~ 1

Author(s):

Dee Anna Glaser ◽

Adelaide A Hebert ◽

Alexander Nast ◽

William P Werschler ◽

Stephen Shideler ◽

...

Keyword(s):

Axillary Hyperhidrosis ◽

Open Label ◽

Open Label Study ◽

Abstract Not AvailableDisclosure: Study supported by Dermira.

Nefazodone Treatment of Adolescent Depression: An Open-Label Study of Response and Biochemistry

Annals of Clinical Psychiatry ◽

10.3109/10401230009147095 ◽

2000 ◽

Vol 12 (2) ◽

pp. 97-100 ◽

Cited By ~ 8

Author(s):

Paul Goodnick ◽

Cecilia Jorge ◽

Thomas Hunter ◽

Adarsh Kumar

Keyword(s):

Adolescent Depression ◽

Open Label ◽

Open Label Study ◽